Resultados de procura - Markus Cornberg

Limitar resultados
  1. 1
    Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity

    Narrowed TCR repertoire and viral escape as a consequence of heterologous immunity por Markus Cornberg

    Publicado 2006
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  2. 2
    Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability

    Clinical Practice Guidelines of the European Association for the study of the Liver – Advancing methodology but preserving practicability por Markus Cornberg, Frank Tacke, Tom H. Karlsen

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Editorial
    Engadir a favoritos
    Gardado en:
  3. 3
    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

    EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients por Markus Cornberg, Marı́a Buti, Christiane S. Eberhardt, Paolo Grossi, Daniel Shouval

    Publicado 2021
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    Natural killer cells act as rheostats modulating antiviral T cells

    Natural killer cells act as rheostats modulating antiviral T cells por Stephen N. Waggoner, Markus Cornberg, Liisa K. Selin, Raymond M. Welsh

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference

    Guidance for Design and Endpoints of Clinical Trials in Chronic Hepatitis B—Report From the 2019 EASL‐AASLD HBV Treatment Endpoints Conference por Markus Cornberg, Anna Suk‐Fong Lok, Norah A. Terrault, Fabien Zoulim

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C

    Direct-Acting Antiviral–Induced Hepatitis C Virus Clearance Does Not Completely Restore the Altered Cytokine and Chemokine Milieu in Patients With Chronic Hepatitis C por Julia Hengst, Christine S. Falk, Verena Schlaphoff, Katja Deterding, Michael P. Manns, Markus Cornberg, Heiner Wedemeyer

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis

    Systemic arterial blood pressure determines the therapeutic window of non‐selective beta blockers in decompensated cirrhosis por Tammo Lambert Tergast, Markus Kimmann, H. Laser, Svetlana Gerbel, Michael P. Manns, Markus Cornberg, Benjamin Maasoumy

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper

    Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper por Tobias Boettler, Philip N. Newsome, Mario U. Mondelli, Mojca Matičič, Elisa Cordero, Markus Cornberg, Thomas Berg

    Publicado 2020
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  9. 9
    Private specificities of CD8 T cell responses control patterns of heterologous immunity

    Private specificities of CD8 T cell responses control patterns of heterologous immunity por Sung-Kwon Kim, Markus Cornberg, Xiaoting Z. Wang, Hong D. Chen, Liisa K. Selin, Raymond M. Welsh

    Publicado 2005
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp>

    Bile acid increase during bulevirtide treatment of hepatitis D is not associated with a decline in <scp>HDV RNA</scp> por Katja Deterding, Cheng‐Jian Xu, Kerstin Port, Christopher Dietz‐Fricke, Xun Jiang, Benjamin Maasoumy, Markus Cornberg, Heiner Wedemeyer

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection

    Clinical long-term outcome of hepatitis D compared to hepatitis B monoinfection por A. Wranke, Benjamin Heidrich, Katja Deterding, Katharina Luise Hupa‐Breier, J. Kirschner, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss

    Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss por Christine L. Zimmer, Franziska Rinker, Christoph Höner zu Siederdissen, Michael P. Manns, Heiner Wedemeyer, Markus Cornberg, Niklas K. Björkström

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity

    Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity por Benedikt Strunz, Julia Hengst, Katja Deterding, Michael P. Manns, Markus Cornberg, Hans‐Gustaf Ljunggren, Heiner Wedemeyer, Niklas K. Björkström

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    EASL Clinical Practice Guidelines on haemochromatosis

    EASL Clinical Practice Guidelines on haemochromatosis por Heinz Zoller, Benedikt Schaefer, Annick Vanclooster, Bill Griffiths, Edouard Bardou–Jacquet, Elena Corradini, Graça Porto, John Ryan, Markus Cornberg

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection

    Value and Kinetics of Virological Markers in the Natural Course of Chronic Hepatitis D Virus Infection por Lisa Sandmann, Valerie Ohlendorf, Alena Friederike Ehrenbauer, Birgit Bremer, Anke Kraft, Markus Cornberg, Katja Deterding, Heiner Wedemeyer, Benjamin Maasoumy

    Publicado 2025
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Memory of mice and men: CD8<sup>+</sup> T‐cell cross‐reactivity and heterologous immunity

    Memory of mice and men: CD8<sup>+</sup> T‐cell cross‐reactivity and heterologous immunity por Liisa K. Selin, Michael A. Brehm, Yuri N. Naumov, Markus Cornberg, Sung‐Kwon Kim, Shalyn C. Clute, Raymond M. Welsh

    Publicado 2006
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  17. 17
    Treatment of Acute Hepatitis C with Interferon Alfa-2b

    Treatment of Acute Hepatitis C with Interferon Alfa-2b por Elmar Jaeckel, Markus Cornberg, Heiner Wedemeyer, Teresa Santantonio, Julika Mayer, M Zankel, Giuseppe Pastore, Manfred Dietrich, Christian Trautwein, Michael P. Manns

    Publicado 2001
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study

    Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: A randomized open-label pilot study por Markus Cornberg, Johannes Hadem, Eva Herrmann, Frank Schuppert, Hartmut Schmidt, Markus Reiser, Oliver Marschal, Martín Steffen, Michael P. Manns, Heiner Wedemeyer

    Publicado 2005
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort

    Drug–Drug Interactions With Novel All Oral Interferon-Free Antiviral Agents in a Large Real-World Cohort por Christoph Höner zu Siederdissen, Benjamin Maasoumy, Fiona Marra, Katja Deterding, Kerstin Port, Michael P. Manns, Markus Cornberg, David Back, Heiner Wedemeyer

    Publicado 2015
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

    Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhos... por F Mettke, Bernhard Schlevogt, Katja Deterding, A. Wranke, Andrea Smith, Kerstin Port, M P Manns, Arndt Vogel, Markus Cornberg, Heiner Wedemeyer

    Publicado 2017
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: